While major depression is generally regarded as a reversible psychiatric illness without lasting changes in the brain, it actually follows a more chronic, treatmentresistant course in up to 20% of subjects (Keller et a/, 1982). Such a course implies that some permanent changes to the brain may have occurred, but previous neuroimaging studies have either ignored the issue or provided only limited evidence for biological correlates (Morinobu et a/, 1991). Hippocampal atrophy has been found in the aftermath of highly stressful life periods, and notably in a small cohon of elderly depressed subjects with recurrent depression (Bremner et a/, 1995; Sheline et a/, 1996; Stein et a/, 1997). In our present study we use a novel voxel-based analysis of magnetic resonance imaging (MRI) scans to compare conical grey matter density between younger subjects with treatmentresistant chronic depression, matched recovered subjects and normal healthy volunteer subjects.
METHOD Subjects
Twenty subjects with treatment-resistant depression, aged between 21 and 65, fulfilling DSM-IV (American Psychiatric Association, 1994) criteria for major depressive disorder (chronic) were recruited from general adult in-patient units and from out-patient clinics in Lothian. The subjects also fulfilled Research Diagnostic Criteria (RDC; Spitzer et a/, 1978) for a primary major depressive disorder. Chronicity was defined by a diagnosis of major depressive episode (DSM-IV) lasting for two or more years continuously. Treatment resistance was assumed if the subjects did not respond to at least two treatments from the following four different pharmacological regimes employed for at least four weeks:
(a) 150 mg of imipramine or an equivalent tricyclic antidepressant;
(b) 60 rng of phenelzine or an equivalent monoamine oxidase inhibitor;
(c) 40 rng of fluoxetine or an equivalent selective serotonin reuptake inhibitor;
(d) six treatments with electroconvulsive therapy (ECT) with seizures >20 seconds each.
All the subjects with chronic depression were on a stable medication for at least two weeks prior to the study, as it was not possible to study the subjects medication free. The subjects with chronic depression had not received electroconvulsive therapy (ECT) for at least three months. Twelve subjects had required at least one psychiatric admission.
Twenty subjects who had recovered from depression previously fulfilling the DSM-IV criteria for a major depressive disorder, and 20 normal healthy volunteer subjects (recruited from hospital secretarial and nursing staff, as well as community volunteers) were also examined. Subjects from both these groups were individually matched with the subjects with chronic depression for age, gender, intelligence and years of education. Subjects who had recovered from depression were matched, for age of onset and for onset of the index episode, with the chronic depression group. Recovery was defined as scoring five or less on the 17-item Hamilton Depression Rating Scale (HDRS; Hamilton, 1960) for at least three months prior to the study. The subjects who had recovered from depression were either on a stable medication for at least two weeks prior to the study, or were medication free.
All subjects were interviewed using the lifetime version of the Schedule for Affective Disorders and Schizophrenia (SADS-L; Endicott & Spitzer, 1978) . Case notes were reviewed in detail, providing RDC diagnoses and allowing lifetime histories of psychiatric illness to be determined. Treatment histories were re-constructed from case notes and from interview. Healthy volunteers had no lifetime history of significant psychiatric illness, using the SADS-L interview schedule. Exclusion criteria for all groups were: previous manic episodes; organic cerebral pathology; neurological illness; significant alcohol or substance misuse; head injury associated with significant loss of consciousness; hypothyroidism or concurrent use of exogenous steroids.
All subjects gave informed written on a SPARC workstation (Sun Microsystropic Gaussian kernel to remove variation consent following a protocol approved by tems Europe Inc) using ANALYZE (CNS due to individual differences in sulcal and the local research ethics committee. Software), and SPM '96 for spatial normalgyral patterns. The segmentation procedure isation and statistical parametric mapping used in this study is more sophisticated (Friston et al, 1995a,b) running in MATthan the method previously applied by assessment LAB (The Mathworks Inc). Wright et a1 (1995) . Grey matter is All subjects underwent neuropsychological and clinical testing in a standardised environment, within a two-day period. Symptom severity was measured using the HDRS and cerebral dominance indexed using a handedness scale (Annett, 1970 
Neuropsychological and clinical

Magnetic resonance image acquisition and analysis
Analysing structural scans usually involves laborious slice by slice measurement of local structures. The use of voxel-based analysis has only recently been extended to the analysis of structural MRI (Wright et al, 1995) , although it has transformed the approach to isotope and MRI-based functional imaging (Friston et al, 1995a,b) . MRI scans of subjects are compared after spatial transformation into a standard brain atlas space to remove variation in overall brain position, size and shape. Subsequent to segmentation of the images, grey or white matter compartments may be compared between groups on a voxel by voxel basis. The technique for spatially transforming and segmenting images into different tissue types is fully automated and operator-independent. All subjects were scanned within one week of the clinical assessment. Magnetic resonance images were acquired on a Siemens 1 Tesla system, using a magnetisation prepared rapid acquisition graded echo (MPRAGE) sequence, with images acquired perpendicular to the anterior-toposterior commissure line. This sequence produces high resolution images with good contrast between white and grey matter (TR=10 ms, TD=SOO ms, flip angle=12", block size=240 mm, 128 contiguous slices with an effective slice thickness of 1.875 mm). Image analysis was performed In ANALYZE, images were first corrected for field inhomogeneities with a phantom image using image algebra, then converted to 8-bit images and flipped to reverse right and left to comply with the neurological convention. Within the SPM '96 software, images were first spatially normalised into standard space and then segmented into grey matter, white matter, cerebrospinal fluid (CSF) and skulVscalp compartments, using an automated and operator-independent process. Spatial normalisation involved reading image data in coronal orientation and linearly deforming them using a 12-point affine transformation to fit a TI-weighted template image which included skull and scalp. Nearest neighbour interpolation was used to preserve tissue type boundaries and the original intensity spectrum of the image. The normalised image has a voxel resolution of 1 x 1 x 2 mm. Images were then segmented using a modified clustering algorithm based on the maximum likelihood 'mixture model ' (Hartigan, 1975) which allows classification of tissue type, as well as tissue density. The algorithm uses a combination of the underlying multinormal distribution of T, relaxation times, and a series of a priori probability images for each tissue type, where each voxel represents the prior probability of tissue at a location belonging to a particular compartment. The multi-normal distribution reflects the distinct T, intensity clusters from different tissue types, with the key assumption that the range of T, relaxation times from the image produce a range of intensities which reflect different tissue types and, within each distribution, different tissue densities. A priori segmented probability images provide approximate spatial distributions of different tissue types. These were derived from averaging the spatially transformed segmented images of grey, white matter and CSF from MRIs of healthy volunteers. The intensity distribution of the probability image ranges between 0 and 1. The algorithm is iterative and has the effect of biasing voxel classification towards the a priori distribution. Prior to statistical comparison, the spatially normalised segments were smoothed with a 12mm full width at half maximum isoclassified having continuous values from 0-1 based on probability, whereas the earlier technique classified tissue only as 0 to 1, in binary fashion. In addition, by smoothing the data, the partial volume effect is used to convert differences in the amount of grey matter locally into differences in intensity. For reasons of economy, only grey matter results are reported in this paper.
Statistical comparison
An ANCOVA model was applied which removed global grey matter density for each subject. This normalises the transformed and segmented brain image to the same total amount of grey matter, while preserving regional differences in grey matter density. Age-effects were also removed by ANCOVA. Differences between groups were displayed as statistical parametric maps (SPMs), with a threshold probability of 1%. Statistical clusters were projected on to a TI-weighted grey matter density template to facilitate interpretation of the results. Corrected probability values were computed which take into account the whole volume examined, the smoothness of the data, the size of the cluster with P<0.01, and the peak effect (Z-value). Group demographic and clinical data were compared using univariate ANOVA and post hoc t-tests to identify specific group differences. Non-continuous variables were compared using the Kruskal-Wallis and Mann-Whimey U and x2 tests, as appropriate. The latter statistics were computed using SPSS version 4.0 for the Macintosh.
RESULTS
Clinical data
The three groups did not statistically differ in age, gender, cerebral hemispheric laterality, years of education, estimated premorbid IQ and the total number of years smoking (Table I) , although there was a tendency for the subjects with chronic depression to have fewer years of education, a lower NART IQ and perhaps to be right-lateralised to a lesser degree. The mean age of onset of first and most recent episodes of depression did not differ between the chronic and recovered groups. Subjects with chronic depression had suffered a longer duration of illness and longer illness episodes. Within the chronic depression group, all were taking antidepressant drugs. In addition, 12 subjects with depression took regular neuroleptic medication, five took lithium and three benzodiazepines. Fourteen subjects with depression had received ECT in the past. Nine of the subjects who had recovered from depression were prescribed antidepressants, one also received neuroleptics and one lithium. Eleven of the subjects who had recovered from depression had previously received ECT. Subjects with chronic depression had moderately severe depressive symptoms (17-item HDRS, mean 20.6, s. 82.4 nmoM (0.58-2.97 &dl) in the afternoon, that is, all subjects were suppressors. Fig. 1 shows grey matter density reductions in subjects with chronic depression compared with healthy control subjects. Reductions were found over large areas of the left temporal neocortex and left anterior hippocampus (Table 2) . Comparison of subjects with chronic depression with depressionrecovered subjects yielded very similar results. Subjects who had recovered depression and control subjects showed no significant differences in grey matter density. We also found an apparent increase in cuneus/precuneus grey matter density in the subjects with chronic depression compared with both subjects who had recovered from depression and the control subjects. This may reflect the consequences of the left hemispheric changes on grey matter values in the former group with relatively normal cuneus/precuneus grey matter. As there was an a prior; hypothesis linking verbal memory with left temporal lobe function, we correlated grey matter density with performance on the AVLT delayed recognition test in the chronic group. Left hippocampal grey matter density was positively correlated with recall of previously learnt verbal material ( Fig. 2 and Table 3 ).
Grey matter density
DISCUSSION
Grey matter abnormalities in chronic depression
We were able to demonstrate that middleaged unipolar subjects with treatment-resistant chronic depression had reduced grey matter density in large areas of the left temporal cortex, including left anterior hippocampus, compared with both healthy control subjects and subjects who had recovered from depression. Well matched depression-recovered subjects did not differ from healthy control subjects. We chose to examine subjects who were symptomatic for two years or more, in line with the definition of chronicity proposed in DSM-IV. In fact, our sample of subjects with chronic depression well exceeded two years of active illness, having a mean episode duration of 197 weeks. This result adds to the evidence accumulating that, in elderly patients, chronicity may be associated with increased ventricle to brain ratio (Roy-Byme et al, 1988) , with decreased temporal (Altshuler, 1993) and amygdala-hippocampal volume (Axelson et al, 1993; Sheline et al, 1996) , as well as the observation that chronic or overwhelming stress may be associated with hippocampal atrophy (Bremner et al, 1995; Stein et al, 1997) .
Functional correlates of grey matter abnormalities
In agreement with a previous study in chronic bipolar illness (McKay et al, 1995) , verbal recognition was significantly impaired in the subjects with chronic depression in our study and, within the group, was correlated with reduced left hippocampal grey matter density. Episodic memory depends on the integrity of the temporal lobes (Mayes & Downes, 1997). Harvey et a1 (1997) compared cognitive function in poor-outcome hospitalised geriatric patients with affective disorders and hospitalised patients with chronic
Treatment-resistant
Recovered from Control subject group F,,,,-probability depression group depression group (n=20) (n =20) Coordinates refer to the voxels with maximum (peak) effect sizes as defined by the brain atlas of Talairach & Tournoux (1988) . H multiple coordinates are given, the cluster of contiguous voxels with an uncomcted P < 0.01 has multiple peak effect sizes. Uncorrected P-values are given for peak effect sizes and for the cluster volumes of contiguous voxel with uncorrected P <O.OI.Corrected P-values have been adjusted for multiple comparisons according to peak effect size. cluster volume, smoothness of data and total volume examined (Friston et 01. 1995b). Results are corrected for age. Coordinates refer to the brain atlas of Talairach & Tournoux (1988) .The multiple coordinates indicate that the cluster of contiguous voxels with an uncorrected P <0.01 has multiple peak effect sizes. schizophrenia and found no group differences, suggesting that the severity of cognitive impairment may correlate with chronicity, regardless of diagnosis. In support of this notion, a correlation of left hippocampal volume with verbal memory performance could be demonstrated in subjects with schizophrenia, who also show reduced hippocampal size (Goldberg et al, 1994) .
Methodological considerations
This is the first application of a new voxelbased analysis of structural MRI, comparing patient groups and control subjects. Voxel-based analysis is generally likely to be more sensitive to localised differences which may be a small pan of, or overlap, the structures (object maps) measured in traditional volumetric approaches (Ebmeier et al, 1998) . Because the results in this study may, therefore, not be detectable with the traditional 'gold standard' volumetry, an independent replication of the results using statistical parametric mapping or another voxel-based method will be essential. One reason for this is that our measure of grey matter density is based on regional TI-relaxation times. Changed TI at the boundary with other compartments may be due to partial volume effects in the presence of structural brain differences, but local changes in brain chemistry may also affect T,. Subjects with depression often restrict their food intake and suffer weight loss, which in turn may result in reversible brain atrophy, similar to that observed in anorexia nervosa (Swayze et al, 1996) , although it is not clear why such atrophy should be localised or lateralised to the left side.
Possible aetiologies of grey matter abnormalities
Grey matter changes can be antecedent to or consequent upon depressive symptoms or their treatment. Obstetric complications may be more frequent in subjects with depression (Guth et al, 1993) . In schizophrenia, left temporal lobe volume reduction may reflect reduced neurodevelopmental cerebral lateralisation (DeLisi etal, 1991) . The subjects with chronic depression in our study showed a similar tendency to less lateralisation, irnplying that neurodevelopmental abnormalities in subjects with unipolar depression, particularly affecting the left temporal lobe, may finally predispose to chronicity. Alternatively, the chronic illness may be responsible for temporal lobe atrophy. Raised levels of cortisol, which are not suppressed by dexamethasone may predict rapid relapse and possibly chronicity (Amsterdam et a1, 1983) . Animal work suggests that chronically raised cortisol can facilitate hippocampal neuronal death, which in nun may cause dysregulation of the hypothalmic-pituitary-adrenal (HPA) axis (Sapolsky et al, 1986) . Dysregulation of the HPA axis can also be found in people with schizophrenia, who have reduced hippocampal volumes. However, since temporal lobe damage may cause hypercortisolaemia, these assoiations do not establish the direction of the effect. Interestingly, the subjects with chronic depression did not exhibit dexamethasone non-suppression, suggesting that hypercortisolaemia was not an important factor maintaining chronicity in this sample. However, since we did not obtain baseline measures of cortisol and this was a cross-sectional study, the possibility of present or previous HPA dysfunction cannot be discounted.
Finally, the treatment of depression may be responsible for localised tissue loss. To test this hypothesis, we correlated the number of ECTs during subjects' lifetimes with grey matter density in the chronic depression group. There were no correlations with hippocampal grey, but there were some neocortical regions with significant correlations extending over temporal and frontal lobes. Whether such associations are causal, and if so in which direction is not clear. Longitudinal studies are required to determine whether cortical atrophy predates particularly severe illnesses which require ECT, or whether ECT causes such changes. Although we have very closely matched groups, the study could be criticised for including chronically depressed and depression-recovered subjects who were taking medication. There is no convincing evidence to suggest that long-term antidepressants or ECT are responsible for structural brain changes (Scott et al, 1995) or changes in cognitive function greater than those produced by depression. Further, there were no grey matter differences between control subjects and the subjects who had recovered from depression, some of whom were on psychotropic medication and had previously received ECT.
